Olema Oncology
Ali S. currently serves as the Senior Director of IT Infrastructure & Operations at Olema Oncology since July 2025. With extensive experience in IT infrastructure and operations, Ali has held key positions at various organizations, including Vir Biotechnology, Inc. as Sr. Director of IT Infrastructure & Operations, and Power Integrations as Head of IT Infrastructure & Security. Additionally, Ali has contributed as a Startup Board Advisor and Technology Architect, providing guidance on technology infrastructure for early-stage companies. Ali's expertise encompasses cloud services, IT project management, and automation to enhance operational efficiencies, supported by a strong educational background with a Master's and Bachelor's degree in Electrical Engineering from Columbia University.
This person is not in any teams
This person is not in any offices
Olema Oncology
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalation and expansion clinical trial of OP-1250. They are supported in their mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies.